Unexpected falsely high vancomycin concentrations in a patient with endocarditis during routine therapeutic drug monitoring

QR Code

Unexpected falsely high vancomycin concentrations in a patient with endocarditis during routine therapeutic drug monitoring

Introduction: Vancomycin is a glycopeptide antibiotic indicated for the treatment of infections caused by methicillin-resistant Staphylococcus aureus. Appropriate vancomycin therapeutic drug monitoring is an essential exercise to improve the achievement of the target therapeutic levels. Case descrip...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Galán-Caballero, María del Rosario Salas-Butrón, Daniel Lozano-Martín, Iván Alejandro Díaz-Rengifo, Isabel Ortega-Madueño, Lucia Diaz-Garcia, Ana Isabel Terleira-Fernández
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2025-06-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	vancomycin interference immunoassay therapeutic drug monitoring
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/5464
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of Vancomycin B and Vancomycin Impurities by Liquid Chromatography
by: S. I. Kuleshova, et al.
Published: (2021-12-01)

Is It Possible to Optimize the Elaboration and Preservation of a Vancomycin Catheter Lock Solution?
by: Marta Díaz-Navarro, et al.
Published: (2025-06-01)

Formulation and Characterization of Bone-Targeting Vancomycin-Loaded Liposomes
by: Basel Karzoun, et al.
Published: (2025-06-01)

The Effects of Shock Vancomycin Concentrations on the Formation of Heteroresistance in Staphylococcus aureus
by: V. V. Gostev, et al.
Published: (2020-12-01)

Correlation of Neutrophil-Lymphocyte Ratio and Critical Illness in Adults on Vancomycin: A Cross-Sectional Study
by: Alfhili MA, et al.
Published: (2025-07-01)

Research progress on the transmission and control of vancomycin-resistant Enterococcus in the environment: a review
by: Hui LI, et al.
Published: (2025-06-01)

Estimation of MRSA Susceptibility to Oxacillin, Cefoxitine, Vancomycin and Daptomyci
by: V. V. Gostev, et al.
Published: (2020-05-01)

The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats
by: Seyhmus Tan, et al.
Published: (2025-06-01)

DRY EXTRACT OF SCUTELLARIA BAICALENSIS GEORGI HEPATOPROTECTIVE ACTION IN VANCOMYCIN IMPLEMENTATION
by: A. A. Potapova, et al.
Published: (2015-09-01)

Prevention of Acute Kidney Injury Related (AKI) related by vancomycin; A Randomized Clinical Trial
by: Mahboubeh Neamatshahi, et al.
Published: (2024-04-01)

Faecal microbiota transplantation to decolonize vancomycin-resistant Enterococcus: A pilot study to evaluate safety and clinical outcome
by: Shu-Min Lin, et al.
Published: (2025-06-01)

Impact of Recovery from Febrile Neutropenia on Intra-Individual Variability in Vancomycin Pharmacokinetics in Pediatric Patients
by: Yukie Takumi, et al.
Published: (2025-06-01)

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis
by: A. B. Prokofiev, et al.
Published: (2022-07-01)

Epidemiology of Vancomycin-Resistant Enterococci in Various Medical Wards
by: A. V. Liubimova, et al.
Published: (2016-08-01)

Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort
by: Laura Wagner, et al.
Published: (2025-07-01)

Spectrophotometric Analysis of Vancomycin Hydrochloride in Pure and Pharmaceutical Injections via Batch and Cloud Point Extraction Techniques
by: Hind S. Al-ward Al-ward, et al.
Published: (2023-04-01)

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections
by: O. S. Tufanova, et al.
Published: (2022-07-01)

Results of Investigation of MRSA Susceptibility to Vancomycin in Clinical Units of Large Multifunctional Hospital and Recommendations on Optimization of Antibacterial Therapy of Staphylococcal Infection
by: V. A. Verikovsky, et al.
Published: (2020-05-01)

Cell Wall Biosynthesis Genes Variability in Methicillin-Resistant Staphylococcus Aureus with Reduced Vancomycin Susceptibility
by: V. V. Gostev, et al.
Published: (2020-05-01)

Optimization of therapeutic drug monitoring of vancomycin in newborns using “Dried Blood Spot” method
by: V. I. Petrov, et al.
Published: (2024-01-01)

Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the “MIC Creep” Phenomenon
by: Eko Setiawan, et al.
Published: (2019-05-01)

Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the “MIC Creep” Phenomenon
by: Eko Setiawan, et al.
Published: (2019-05-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

A real-world study of the optimal cut-off value for vancomycin trough concentration associated with outcomes in children infected with drug-resistant Gram-positive bacteria
by: Yinghui Yan, et al.
Published: (2025-07-01)

Impact of tranexamic acid on the efficacy of vancomycin and meropenem against periprosthetic joint infections: an in vitro analysis
by: Liqin Yao, et al.
Published: (2025-07-01)

Fluorescent–Electrochemical–Colorimetric Triple-Model Immunoassays with Multifunctional Metal–Organic Frameworks for Signal Amplification
by: Ning Xia, et al.
Published: (2025-06-01)

The Y58D mutation in rpsJ gene is correlated with tigecycline and eravacycline combined resistance in ST80 vancomycin-resistant Enterococcus faecium isolates
by: Felice Valzano, et al.
Published: (2025-06-01)

Fluorescence Polarization Immunoassay for Express Control of Antibiotic Levels: Design and Characteristics for Chloramphenicol, as an Example
by: S. A. Eremin, et al.
Published: (2020-05-01)

Epidemiological features of infections/colonization, caused by vancomycin-resistant enterococci in Saint-Petersburg hospitals in 2017–2020
by: M. A. Chervyakova, et al.
Published: (2022-07-01)

Mathematical Modeling of Eyeball Vitreous Cavity and Software Based Thereon for Automatic Calculation of Individual Doses of Antibiotics for Intravitreal Injection in Treating Bacterial Endophthalmitis
by: V. N. Kazaykin, et al.
Published: (2020-04-01)

Anti-Infection Efficacy, Osteogenesis Potential, and Biocompatibility of 3D Printed PLGA/Nano-Hydroxyapatite Porous Scaffolds Grafted with Vancomycin/DOPA/rhBMP-2 in Infected Rabbit Bone Defects
by: Ke re mu ALM, et al.
Published: (2025-05-01)

Molecular Characterization of Vancomycin-Resistant <i>Enterococcus</i> spp. from Clinical Samples and Identification of a Novel Sequence Type in Mexico
by: Raúl Alejandro Atriano Briano, et al.
Published: (2025-06-01)

Study of Antibacterial Activity and Energy of Formation of Peptide Ligand Complexes With Hybrid Antibiotics Vancomycin-Azithromycin and Eremomycin-Azithromycin
by: E. E. Bykov, et al.
Published: (2020-05-01)

Design of Novel Carboxamides of Eremomycin and Vancomycin with 4- or 3-Amino Methyl Phenyl Boric Acid and Their Investigation
by: E. N. Bychkova, et al.
Published: (2020-05-01)

Study of the Effectiveness of Precision Doses of Antibiotics in the Treatment of Induced Acute Bacterial Postoperative Endophthalmitis in an Experiment
by: V. N. Kazajkin, et al.
Published: (2019-12-01)

Immunoassays in food analysis
Published: (1985)

Covalent Organic Frameworks for Immunoassays: A Review
by: Suling Yang, et al.
Published: (2025-07-01)

Layer-by-layer gelatin/chitosan polyelectrolyte coated nanoparticles on Ti implants for prevention of implant-associated infections
by: T. Sangfai, et al.
Published: (2017-01-01)

Complicaciones de la administración intraósea de vancomicina en artroplastia total de cadera
by: W.F. Martínez, et al.
Published: (2025-07-01)

FEATURES OF CYTOKINE REGULATION IN PATIENTS WITH MECHANICAL JAUNDICE OF MALIGNANT GENESIS
by: O. V. Smirnova, et al.
Published: (2018-01-01)